Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022 Aug 16, 2022 12:46PM
Field Trip Announces Closing of Plan of Arrangement and $19.9 Million Private Placement Financing Aug 11, 2022 04:28PM
Field Trip Health Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 16, 2022, at 8:30 AM ET Aug 8, 2022 08:00AM
Field Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange Aug 4, 2022 06:29PM
Field Trip Announces First Dosings in Phase I Clinical Study of FT-104 Jul 21, 2022 07:30AM
View Older Stories

Jun 29, 2022 10:00PM Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Including Corporate Reorganization
Jun 29, 2022 04:37PM Field Trip Health Ltd. Receives Final Court Approval for Reorganization of the Discovery and Wellness Businesses Into Two Publicly Traded Companies
Jun 27, 2022 08:21PM Field Trip Health Ltd. Announces Voting Results From Special Shareholder Meeting
Jun 23, 2022 07:41AM Field Trip Health Ltd. to Present at the H.C. Wainwright 1st Annual Mental Healthcare Conference on June 27, 2022
Jun 22, 2022 02:41PM Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ET
Jun 14, 2022 06:03PM Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and Postponement of Shareholder Meeting Date
May 12, 2022 07:30AM Field Trip and Nue Life Are Collaborating To Bring Psychedelic Therapy Into the Home
Apr 29, 2022 08:12AM Field Trip Health Ltd. to Participate in Upcoming Investor Conferences in May 2022
Apr 28, 2022 06:19PM Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies
Apr 18, 2022 09:00AM Field Trip Health Ltd. to Participate in Upcoming Investor Conferences
Apr 5, 2022 07:51AM Field Trip Health (FTRP) Granted US Patent Covering Novel Psychedelic Molecule FT-104
Apr 5, 2022 07:51AM Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104
Mar 23, 2022 08:00AM Field Trip Health Ltd. to Participate in Maxim Group 2nd Annual Virtual Growth Conference
Mar 9, 2022 08:00AM Field Trip Health Ltd. to Participate in 34th Annual Roth Conference in March 2022
Mar 3, 2022 07:45AM Field Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care
Feb 15, 2022 05:16PM Field Trip Health (FTRP) Provides Business Update, Reports Q3
Feb 15, 2022 05:15PM Field Trip Health Ltd. Reports Third Fiscal Quarter 2022 Financial Results and Provides Business Update
Feb 1, 2022 08:00AM Field Trip Health Ltd. Schedules Third Fiscal Quarter 2022 Financial Results Conference Call for February 16, 2022 at 8:30 AM ET
Jan 18, 2022 08:00AM Field Trip Health Ltd. to Participate in Citi’s Psychedelic Drug Video Call Series
Jan 11, 2022 10:00AM Field Trip Health (FTRP) Receives Notice of Allowance for US Patent Application Covering FT-104
Jan 11, 2022 10:00AM Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development
Jan 6, 2022 08:00AM Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies
Jan 5, 2022 07:30AM Field Trip Health Ltd. to Participate in H.C. Wainwright Bioconnect Virtual Conference in January 2022
Dec 14, 2021 07:30AM Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté as Head of Quality
Dec 1, 2021 07:30AM Field Trip Health Ltd. to Participate in Upcoming Conferences in December 2021
Nov 15, 2021 06:05PM Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update
Nov 3, 2021 07:30AM Field Trip Health Ltd. to Participate in Upcoming Conferences in November 2021
Nov 2, 2021 07:30AM Field Trip Health Ltd. Schedules Second Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, November 16, 2021 at 8:30 AM ET
Oct 19, 2021 07:55AM Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton
Oct 12, 2021 07:30AM Field Trip Health Ltd. To Present At The KCSA Psychedelics Virtual Investor Conference On October 13th
Sep 24, 2021 06:10PM Field Trip Health Announces Voting Results From the Annual General and Special Meeting of Shareholders
Sep 10, 2021 08:48AM Field Trip Health Ltd. to Participate in Four Investor Conferences in September
Sep 9, 2021 07:30AM Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104
Aug 31, 2021 07:55AM Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers; Also Launches Training Programs To
Aug 16, 2021 06:12PM Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results
Aug 10, 2021 07:55AM Field Trip Health Ltd. Schedules First Fiscal Quarter 2022 Financial Results Conference Call for Tuesday, August 17, 2021 at 8:30 am ET
Jul 27, 2021 03:32PM Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP
Jul 23, 2021 07:50AM Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol "FTRP"
Jul 8, 2021 05:00PM Field Trip Health Ltd. to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
Jun 24, 2021 05:05PM Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results
Jun 17, 2021 07:30AM Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call for Friday, June 25, 2021 At 8:00 am ET
Jun 15, 2021 07:30AM Field Trip Health Ltd. Announces Completion of DMPK Studies, Engineering Batch for FT-104, Its Novel Psychedelic Compound
Jun 8, 2021 07:30AM Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market
Jun 3, 2021 07:30AM Field Trip Health Ltd. to Commence Trading on the Toronto Stock Exchange on June 7, 2021
May 27, 2021 07:30AM Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange
May 20, 2021 07:30AM Former Senate Majority Leader Tom Daschle Appointed Special Adviser to Field Trip Health Ltd.
May 18, 2021 07:30AM More than 80% of Americans report one or more symptoms of depression, and many have turned to substances to cope with negative emotions during COVID-19 Pandemic, according to Field Trip Health’s Fir
May 6, 2021 09:10AM Field Trip Health Ltd. Announces DTC Eligibility
May 4, 2021 07:30AM Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston; Locations of Next 5 Field Trip Health Centers
Feb 16, 2021 05:29PM Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results
View Older Stories